A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...

An Austin-based pain management doctor and his medical practice have agreed to pay more than $13.6 million to settle allegations that they improperly billed federal and state health care programs for ...

The US military carried out a strike Thursday on a suspected drug boat in the Eastern Pacific, killing four people on board, according to a social media post from US Southern Command. “Southern Spear ...

The U.S. military carried out its 22nd strike on a suspected drug-running vessel Thursday, targeting a small boat in the eastern Pacific after nearly a three-week pause, U.S. Southern Command ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...

The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about its effectiveness and availability in Canada. Lecanemab is a lab-made ...

Community advocates and health policy experts say they have more questions than answers when it comes to drug treatment legislation to be introduced this fall by the Saskatchewan government. Health ...

The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking deals directly with Big Pharma companies in an attempt to bring U.S. prices in ...

WASHINGTON (AP) — Within a week of Donald Trump’s election, Sen. Lindsey Graham counseled the president-elect to quickly send a message to the drug cartels from the White House. “Blow up something,” ...

The FDA has signed off on Johnson & Johnson’s highly anticipated bladder cancer drug Inlexzo, marking an advance in the ability to care for patients who otherwise face bladder removal and limited ...